Equity

BMEZ

Health Sciences Trust II

Overview

Loading

Performance

Performance

Growth of Hypothetical $10,000

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart
  1y 3y 5y 10y Incept.
62.96 - - - 42.21
Market Price (%) 54.53 - - - 32.04
  YTD 1m 1y 3y 5y 10y Incept.
-5.51 - 62.96 - - - 50.83
Market Price (%) -7.06 - 54.53 - - - 38.31
  2016 2017 2018 2019 2020
Total Return (%) - - - - -

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.


Returns are shown net of advisory fees paid by the fund and net of the fund’s operating fees and expenses. Investors who purchase shares of the fund through an investment adviser or other financial professional may separately pay a fee to that service provider. Past performance is not indicative of future results.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Key Facts

Key Facts

Net Assets as of May 06, 2021 $3,227,452,148
Size of Fund (Millions) as of May 06, 2021 $3,227.5 M
Share Class launch date Jan 29, 2020
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Health
Lipper Classification Sector Equity Funds
CUSIP 09260E105
Management Fee as of Dec 31, 2020 1.25%
Gross Expense Ratio as of Dec 31, 2020 1.31%
Shares Outstanding as of May 06, 2021 112,669,825
Number of Holdings -
Managed Assets as of May 06, 2021 $3,227,452,147.84
Premium Discount as of May 06, 2021 -6.39%

Portfolio Characteristics

Portfolio Characteristics

Average Market Cap (Millions) as of May 05, 2021 $ 18,387.3 M
Distribution Rate as of May 06, 2021 6.49%
Type of Options Single Stock
% Overwritten as of May 05, 2021 21.61

ESG Integration

ESG Integration

ESG integration is the practice of incorporating material environmental, social and governance (ESG) information or insights alongside traditional measures into the investment decision process to improve long term financial outcomes of portfolios. Unless otherwise stated in Fund documentation or included within the Fund’s investment objective, inclusion of this statement does not imply that the Fund has an ESG-aligned investment objective, but rather describes how ESG information is considered as part of the overall investment process.


The Fund manager takes into account ESG considerations in combination with other information in the research and decision phases of the investment process. The Fund manager conducts regular portfolio reviews between with the Risk and Quantitative Analysis group and the Chief Investment Officers, which may include discussion of material ESG risks, as well as exposure to sustainability-related business involvements, climate-related metrics, and other factors. The Fund also includes an option overlay strategy; ESG factors are not considered in the investment process for the options overlay strategy.

Ratings

Holdings

Holdings

as of May 05, 2021
Name Weight (%)
GENMAB A/S 3.19
OAK STREET HEALTH INC 2.22
SEAGEN INC 2.20
INTUITIVE SURGICAL INC 1.86
TELEFLEX INCORPORATED 1.77
AMEDISYS INC 1.74
STRAUMANN HOLDING AG 1.66
ALCON AG 1.63
ZIMMER BIOMET HOLDINGS INC 1.60
WUXI APPTEC CO LTD 1.60
GENMAB A/S 3.19
OAK STREET HEALTH INC 2.22
SEAGEN INC 2.20
INTUITIVE SURGICAL INC 1.86
TELEFLEX INCORPORATED 1.77
AMEDISYS INC 1.74
STRAUMANN HOLDING AG 1.66
ALCON AG 1.63
ZIMMER BIOMET HOLDINGS INC 1.60
WUXI APPTEC CO LTD 1.60

Exposure Breakdowns

Exposure Breakdowns

as of May 05, 2021

% of Market Value

Type Fund
as of May 05, 2021

% of Market Value

Type Fund
as of May 05, 2021

% of Market Value

Type Fund
as of May 05, 2021

% of Market Value

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team
Kyle McClements
Kyle McClements
Christopher Accettella
Christopher Accettella
Portfolio Manager

Literature

Literature